Causes Or Cures

The First Real-Time Platform to Predict COVID-19 Vaccine Effectiveness, with Professor Maggie Wang

August 11, 2022 Dr. Eeks/ Professor Maggie Wang Episode 112
Causes Or Cures
The First Real-Time Platform to Predict COVID-19 Vaccine Effectiveness, with Professor Maggie Wang
Show Notes

In this episode of Causes or Cures, Dr. Eeks chats with Professor Maggie Wang about the first, real-time platform to predict the effectiveness of COVID-19 vaccines. The podcast is based on her and her team's work published in Nature Medicine in June of  2022.  The platform has the potential to be used for other vaccines as well.
In the podcast, Professor Wang will discuss the research behind the platform, how vaccine effectiveness relates to "genetic distance"; how, when using the platform, the different COVID-19 vaccine platforms compare; why over 80% of variation in vaccine effectiveness is due to the genetic distance measure; how the platform can predict vaccine effectiveness by vaccine type and geopgraphical area; reverse vaccinology, and the larger, practical implications of this real-time platform.

Professor Wang is founder and director of BethBio, a biotech company located in Hong Kong that focuses on vaccine development and translating frontier research results into vaccine technologies. She is also the Co-Director of the Master of Science Program in Epidemiology and Biostatistics at the Chinese University of Hong Kong and a Review Editor for Human Genetics.

You can contact Dr. Eeks at bloomingwellness.com.
Follow Dr. Eeks on Instagram here.
Or Facebook here.
Or Twitter.
Subcribe to her newsletter here!






Support the show